Bethany Pan,, PharmD, Ryan Beechinor, PharmD, BCPS, BCOPMetastatic melanoma presents as a highly immunogenic form of cancer characterized by extensive mutational load and variations within and between tumors. This unique…
Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP, and Amy Barker, MSN, APRN, FNP-CWe have witnessed dismal overall outcomes in individuals with relapsed and/or refractory (R/R) multiple myeloma (MM) for many years. However,…
Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP The bispecific antibodies have shown an impressive response rate with tolerable safety profile in patients with relapsed and refractory multiple myeloma (R/R MM). The Food…
Stephen Michael Clark, PharmD BCOP There have been some exciting advancements in immunotherapy for cancer in the past year, particularly hematologic malignancies. One such advancement is a group of therapies…
Jina Yun, PharmD Breast cancer is the most prevalent cancer in women in the United States, affecting 1 out of 8 women.1 It is the second leading cause of cancer-related…
Kim Navarrete, MSN, APRN, FNP-C, OCN, and Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP Multiple myeloma (MM) is a hematologic malignancy associated with the clonal proliferation of plasma cells. Despite decades of…
Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP The Food and Drug Administration approved Carvykti (ciltacabtagene autocleucel, Janssen Biotech Inc.) in February 2022 making it the second chimeric antigen receptor (CAR) T-cell therapy…
The Oncology Connection Fam-trastuzumab-deruxtecan-nxki (Enhertu, Daiichi-Sankyo/AstraZeneca), or T-DXd, led to a high intracranial response rate in patients with active brain metastases from human epidermal growth factor receptor 2 (HER2)-positive breast…
Megan B. May, PharmD, BCOP, and Tori A. Gray, PharmD Candidate 2022 Non-small cell lung cancer (NSCLC) is the third most common type of cancer in the Unites States (US).…
Fatima Khan, PharmD, and Ila M. Saunders, PharmD, BCOP Chronic graft-vs-host disease (cGVHD) is one of most common, yet severe, consequences of allogeneic hematopoietic stem cell transplantation. Occurring in up…